John Borrill
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 12, 2023
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities - Erratum.
Journal: International journal of technology assessment in health care
Published: May 16, 2022
A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: May 09, 2022
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities.
Journal: International journal of technology assessment in health care
Published: March 25, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: March 15, 2022
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
Journal: MDM policy & practice
Published: July 07, 2021
Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making.
Journal: PharmacoEconomics - open
Published: June 05, 2021
Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma.
Journal: JCO clinical cancer informatics
Published: March 25, 2021
What Did Time Tell Us? A Comparison and Retrospective Validation of Different Survival Extrapolation Methods for Immuno-Oncologic Therapy in Advanced or Metastatic Renal Cell Carcinoma.
Journal: PharmacoEconomics
Published: December 12, 2020
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals.
Journal: International journal of technology assessment in health care
Published: July 04, 2020
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective.
Journal: Journal for immunotherapy of cancer
Published: June 12, 2020
Last Updated: 09/26/2026